4.7 Article

Identification of Piperlongumine as Potent Inhibitor of Necroptosis

Journal

DRUG DESIGN DEVELOPMENT AND THERAPY
Volume 17, Issue -, Pages 1387-1394

Publisher

DOVE MEDICAL PRESS LTD
DOI: 10.2147/DDDT.S397971

Keywords

piperlongumine; natural product; drug repositioning; necroptosis; RIPK1

Ask authors/readers for more resources

In this study, it was found that piperlongumine, an alkaloid isolated from the long pepper plant, has inhibitory effects on excessive necroptosis, which contributes to the pathogenesis of various inflammatory and neurodegenerative diseases. The results showed that piperlongumine significantly improved cell viability and inhibited TNF alpha-induced systemic inflammatory response syndrome (SIRS) in mice. Therefore, piperlongumine has potential clinical translation value for the treatment of diseases associated with necroptosis and SIRS.
Purpose: Excessive necroptosis contributes to the pathogenesis of several inflammatory and neurodegenerative diseases. Here, using a high-throughput screening approach, we investigated the anti-necroptosis effects of piperlongumine, an alkaloid isolated from the long pepper plant, in vitro and in a mouse model of systemic inflammatory response syndrome (SIRS). Methods: A natural compound library was screened for anti-necroptosis effects in cellular. The underlying mechanism of action of the top candidate piperlongumine was explored by quantifying the necroptosis marker phosphorylated receptor-interacting protein kinase 1 (p-RIPK1) by Western blotting. The anti-inflammatory effect of piperlongumine was assessed in a tumor necrosis factor alpha (TNF alpha)-induced SIRS model in mice. Results: Among the compounds investigated, piperlongumine significantly rescued cell viability. The half maximal effective concentration (EC50) of piperlongumine for inhibiting necroptosis was 0.47 mu M in HT-29 cells, 6.41 mu M in FADD-deficient Jurkat cells, and 2.33 mu M in CCRF-CEM cells, while the half maximal inhibitory concentration (IC50) was 95.4 mu M in HT-29 cells, 93.02 mu M in FADD-deficient Jurkat cells, and 161.1 mu M in CCRF-CEM cells. Piperlongumine also significantly inhibited TNF alpha-induced intracellular RIPK1 Ser166 phosphorylation in cell lines and significantly prevented decreases in body temperature and improved survival in SIRS mice. Conclusion: As a potent necroptosis inhibitor, piperlongumine prevents phosphorylation of RIPK1 at its activation residue Ser166. Piperlongumine thus potently inhibits necroptosis at concentrations safe enough for human cells in vitro and inhibits TNF alpha-induced SIRS in mice. Piperlongumine has potential clinical translational value for the treatment of the spectrum of diseases associated with necroptosis, SIRS.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available